This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Archives of General Psychiatry | |
|---|---|
| Title | Archives of General Psychiatry |
| Discipline | Psychiatry |
| Publisher | American Medical Association |
| Country | United States |
| History | 1959–2013 |
| Frequency | Monthly |
Archives of General Psychiatry Archives of General Psychiatry was a leading peer-reviewed medical journal focused on research in psychiatry and clinical neuroscience. Published monthly by the American Medical Association from 1959 until its relaunch in 2013, the journal published influential clinical trials, epidemiological studies, and neurobiological research that shaped practice at institutions such as Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. Authors from universities including Harvard University, Stanford University, University of California, San Francisco, and Yale University frequently contributed.
Established in 1959, the journal emerged during a period when figures like Frederic Childs (editorial leadership) and contributors affiliated with Rockefeller University shaped psychiatric publishing. During the 1960s and 1970s, it featured work alongside contemporaries such as The Lancet, British Medical Journal, and New England Journal of Medicine and intersected with debates involving scholars from Columbia University, University of Pennsylvania, and University of Chicago. The journal published during landmark eras that included the influence of investigators connected to National Institutes of Health, National Institute of Mental Health, and research programs at King's College London and Oxford University. In 2013 the title was reorganized under the AMA imprint as part of a rebranding that echoed transformations at journals like JAMA and JAMA Psychiatry.
The journal prioritized original research on topics including clinical trials conducted at Cleveland Clinic, longitudinal cohort studies from Duke University, neuroimaging investigations involving teams at University College London, and genetic studies linked to Broad Institute collaborations. Editorial policy emphasized randomized controlled trials from centers such as Johns Hopkins University School of Medicine, translational work bridging laboratories like Salk Institute and clinical services at UCLA Health, and policy-relevant analyses producing guidance read by clinicians at Mount Sinai Hospital and Cincinnati Children's Hospital Medical Center. Peer review drew on reviewers affiliated with institutions including University of Toronto, McGill University, and Karolinska Institutet. The journal also required disclosure in line with standards set by organizations such as the International Committee of Medical Journal Editors and ethical oversight compatible with committees at World Health Organization and Food and Drug Administration.
Published monthly, the journal was distributed through the American Medical Association's networks and abstracted in major databases including PubMed, MEDLINE, and Scopus. Its articles were indexed alongside content from Nature, Science, and specialty outlets such as Biological Psychiatry and Journal of Clinical Psychiatry. Subscription and institutional access were common at libraries such as the Library of Congress and university collections at University of Cambridge and University of Oxford. Citation metrics compared with titles like BMJ and The Lancet Psychiatry influenced academic promotion decisions at universities such as Princeton University and Columbia University.
The journal published influential studies that had measurable impact on practice and research. Landmark randomized trials involving antidepressant treatments included investigators from Mayo Clinic and Vanderbilt University Medical Center; epidemiological cohorts such as those conducted at Framingham Heart Study-linked teams informed comorbidity research. Neuroimaging and genetics papers linked to research centers like Cold Spring Harbor Laboratory and National Institute of Mental Health shaped subsequent work at Harvard Medical School and Imperial College London. Policy-relevant meta-analyses cited regulatory deliberations at the European Medicines Agency and Food and Drug Administration. The journal’s articles were frequently referenced in guidelines from bodies such as the American Psychiatric Association and influenced curricula at institutions like Stanford University School of Medicine and Yale School of Medicine.
Editors and editorial board members were drawn from leading centers including Johns Hopkins University, University of California, Los Angeles, McGill University Health Centre, and University of Melbourne. The publisher, American Medical Association, managed production, distribution, and archiving, working with library consortia at Cornell University and University of Michigan. Editorial policies aligned with practices advocated by organizations such as the Committee on Publication Ethics and collaborations with indexing bodies like Clarivate Analytics supported impact factor calculations used by promotion committees at University of Pennsylvania and Northwestern University.
The journal was widely respected among clinicians and researchers at institutions such as Massachusetts Institute of Technology and Kennedy Institute (note: institutional psychiatric centers), and it retained a significant citation footprint across disciplines represented at Princeton University and University of British Columbia. Its legacy includes shaping training at residency programs at New York University School of Medicine and influencing systematic reviews cited by Cochrane Collaboration and guideline committees at World Health Organization. The rebranding and relaunch into a successor publication under the American Medical Association umbrella reflected broader trends seen at journals like The BMJ and PLOS Medicine in editorial consolidation and digital transition.
Category:Psychiatry journals